Antony, France, 05 June 2014 -STALLERGENES S.A. (Euronext Paris), world leader in sublingual immunotherapy, announced today that it will be present at the 3rd Citi European Healthcare Conference, to be held on June 19-20, 2014 at its Sterling Square offices in London.

This conference brings together members of the investment community with some of the largest and most innovative companies from the healthcare and biotechnology sectors, ranging from emerging fast-growth companies to global industry leaders.

Peter Bühler, Chief Financial Officer of STALLERGENES, will be present on Friday, June 20, 2014 in order to meet investors and offer a global overview of the Company. 

distributed by